Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENTER: Heparin for VTE prevention after radical prostatectomy
NCT03006562Phase 4Terminated
- Sponsor
- Johns Hopkins University
- Start
- Jul 2017
- Primary completion
- Nov 2019
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of heparin in venous thromboembolism (VTE), sponsored by Johns Hopkins University. Started Jul 2017; status: terminated.
02
Drugs
heparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT03006562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03006562.